CME/CE

Use the tool below to view all available Global Neurology Academy Series

When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic AD
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic AD
CME/CE Virtual Event
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic AD
June 03, 2026
06:00 PM - 07:00 PM CEST
1.00 credit
FXIa Remix! Keeping the Flow Without Missing a Beat
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CE
FXIa Remix! Keeping the Flow Without Missing a Beat
Mike Sharma, MD, MSc, FRCPC; Ashkan Shoamanesh, MD
0.50 credits
- Mike Sharma, MD, MSc, FRCPC
- Ashkan Shoamanesh, MD
- Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
0.50 credits
CME/CE In-Person & Virtual Event
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
Chicago, Illinois
1.50 credits
CME/CE In-Person Event
Advancing Acromegaly Care: Diving Deeper Into Diagnosis, Guideline Application, and Emerging Therapies—A Fireside Chat With Expert Perspectives
June 15, 2026
Chicago, Illinois
1.50 credits
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
CME/CE Virtual Event
Redefining gMG Management: FcRn Antagonists and the New Era of Precision Neurology
September 30, 2026
11:45 AM - 12:45 PM ET
Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
CME/CE
Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
Diana Castro, MD; Jonathan Strober, MD
0.25 credits
- Diana Castro, MD
- Jonathan Strober, MD
0.25 credits
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
CME/CE
Primary Care for the Brain: Prevention and Early Detection of Cognitive Decline
Emily D. Clark, DO; Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
1.00 credit
- Emily D. Clark, DO
- Tracey M. Piparo, PA-C, CAQ-PMHC, DFAAPA
- Susan Scanland, MSN, CRNP, GNP-BC, CDP
- Anthony J. Viera, MD, MPH
1.00 credit
New Pathways in the Treatment of DMD
New Pathways in the Treatment of DMD
CME/CE
New Pathways in the Treatment of DMD
Erika Finanger, MD, MS; Aravindhan Veerapandiyan, MD
1.00 credit
- Erika Finanger, MD, MS
- Aravindhan Veerapandiyan, MD
1.00 credit
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Christoph U. Correll, MD; Jonathan M. Meyer
0.25 credits
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
CME/CE
Mechanism-Driven gMG Therapy: FcRn Antagonists and the Rise of Precision Neurology
Neelam Goyal, MD; Christyn Edmundson, MD
0.50 credits
- Neelam Goyal, MD
- Christyn Edmundson, MD
0.50 credits
From Resistance to Response: Evolving Strategies in MDD Management
From Resistance to Response: Evolving Strategies in MDD Management
CME/CE Broadcast Replay
From Resistance to Response: Evolving Strategies in MDD Management
Joseph F. Goldberg, MD
1.00 credit
- Joseph F. Goldberg, MD
1.00 credit
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
CME/CE
Advances in the Treatment of Neuropsychiatric Symptoms of Alzheimer's Disease: Early Recognition, Diagnosis, and Innovative Emerging Therapies
Marwan Sabbagh, MD, FAAN; Alireza Atri, MD, PhD
1.00 credit
- Marwan Sabbagh, MD, FAAN
- Alireza Atri, MD, PhD
- Christoph U. Correll, MD
1.00 credit
Treatment of a Broader Population of Patients With DMD
Treatment of a Broader Population of Patients With DMD
CME/CE
Treatment of a Broader Population of Patients With DMD
Crystal Proud, MD; Erika Finanger, MD, MS
1.00 credit
- Crystal Proud, MD
- Erika Finanger, MD, MS
1.00 credit
Recognizing Early Signs of LGMD2I/R9 
Recognizing Early Signs of LGMD2I/R9 
MinuteCE®
Recognizing Early Signs of LGMD2I/R9 
John Vissing, MD, DMSci
1.00 program credit
- John Vissing, MD, DMSci
1.00 program credit
Advancing Care: Clinical Innovations on the Horizon 
Advancing Care: Clinical Innovations on the Horizon 
MinuteCE®
Advancing Care: Clinical Innovations on the Horizon 
John Vissing, MD, DMSci
1.00 program credit
- John Vissing, MD, DMSci
1.00 program credit
Integrating Perspectives: The Value of Patient and Caregiver Input
Integrating Perspectives: The Value of Patient and Caregiver Input
MinuteCE®
Integrating Perspectives: The Value of Patient and Caregiver Input
John Vissing, MD, DMSci; Conrad Weihl, MD, PhD
1.00 program credit
- John Vissing, MD, DMSci
- Conrad Weihl, MD, PhD
1.00 program credit

CME/CE

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

CME/CE

Popular

Title